At BYQM®, we are dedicated to providing patients with a seamless and efficient experience in exploring diverse, uncharted treatment options. Leveraging advanced artificial intelligence and big data analytics, we strive to provide each individual with a personalized care plan that is carefully tailored to their unique healthcare requirements and preferences.
Our comprehensive molecular analysis examines over 20,000 unique genes and their complex interactions. By harnessing the genetic insights derived from the patient’s tumor tissue sample, we are able to decipher the underlying biological mechanisms that contribute to increased disease risk and progression. This enhanced understanding of the patient’s disease state allows us to offer more personalized and targeted management approaches.
Contact us directly or through your healthcare provider to learn more.
Disclaimer: This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The use of this test does not guarantee that a patient will be matched to a specific treatment.